Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors.

Ľudmila Křížová Iva Benesova Petra Zemanova Jan Spacek Zuzana Ozaniak Strizova Zuzana Humlova Veronika Mikulová Lubos Petruzelka Michal Vocka

Published in: Journal of cancer research and clinical oncology (2024)

Our work suggests that parameters from peripheral venous blood may be potential biomarkers in NSCLC patients on ICI. The baseline values of Tregs, C3, monocytes, and MPV are especially recommended for further investigation.

Keyphrases

end stage renal disease
peripheral blood
ejection fraction
small cell lung cancer
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
advanced non small cell lung cancer
immune response
dendritic cells
tyrosine kinase